Disease | benign schwannoma |
Comorbidity | C0085113|neurofibromatosis |
Sentences | 24 |
PubMedID- 26377980 | Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2. |
PubMedID- 24718755 | Audiovestibular characteristics of small cochleovestibular schwannomas in neurofibromatosis type 2. |
PubMedID- 24393766 | Two phase ii clinical trials (nct01207687, nct01125046) are assessing the effectiveness of bevacizumab in treating neurofibromatosis 2 patients with symptomatic vestibular schwannomas and recurrent or progressive meningiomas. |
PubMedID- 22805104 | Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients. |
PubMedID- 24335931 | Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2. |
PubMedID- 21817944 | Objectives: to discuss our management strategy of vestibular schwannoma in patients with neurofibromatosis type 2 (nf2). |
PubMedID- 22483820 | The focus is on management of sporadic, unilateral vestibular schwannomas, because patients with neurofibromatosis type 2 pose different management problems best discussed separately. |
PubMedID- 22681725 | Additionally, this method of drug delivery may have important implications in the treatment of patients with vestibular schwannomas associated with neurofibromatosis type 2. |
PubMedID- 24338149 | Pediatric intramedullary schwannoma without neurofibromatosis is extremely rare with only five cases reported so far. |
PubMedID- 20406973 | Patients with bilateral vestibular schwannomas associated with neurofibromatosis type 2 (nf2) experience significant morbidity such as complete hearing loss. |
PubMedID- 23225215 | They are usually solitary and encapsulated masses, but multiple schwannomas may be associated with neurofibromatosis type 2. the tumour may grow through the adjacent intervertebral foramen and spinal canal to produce a “dumbbell” or “hourglass” configuration. |
PubMedID- 23413263 | Loss of the merlin tumour suppressor causes abnormal de-differentiation and proliferation of schwann cells and formation of schwannoma tumours in patients with neurofibromatosis type 2. |
PubMedID- 22004800 | Bevacizumab treatment for vestibular schwannomas in neurofibromatosis type two: report of two cases, including responses after prior gamma knife and vascular endothelial growth factor inhibition therapy. |
PubMedID- 20150363 | Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. |
PubMedID- 23649401 | schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging. |
PubMedID- 26287269 | Factors influencing the growth rate of vestibular schwannoma in patients with neurofibromatosis type 2. |
PubMedID- 23453897 | We present a case of macrodactyly of the small finger associated with a digital nerve plexiform schwannoma in a patient with neurofibromatosis type 2. |
PubMedID- 23407292 | Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results. |
PubMedID- 23546912 | Cerebral hernia caused by a thoracic surgery for multiple schwannomas in a patient with neurofibromatosis type 2. |
PubMedID- 23351479 | Although abnormal gag reflexes have been reported in cases of glossopharyngeal schwannoma and neurofibroma in patients with neurofibromatosis-1, a gag reflex has not been reported previously as a complication of im in the head and neck. |
PubMedID- 26108240 | Bevacizumab treatment for vestibular schwannoma in a patient with neurofibromatosis type 2: hearing improvement and tumor shrinkage. |
PubMedID- 20736812 | We sought to determine the activity of erlotinib for progressive vestibular schwannoma (vs) associated with neurofibromatosis 2 (nf2). |
PubMedID- 21926040 | Multiple cutaneous plexiform schwannomas revealing neurofibromatosis type 2 in a child - report of a novel mutation in this rare association. |
PubMedID- 25362541 | Vestibular schwannoma in a patient with neurofibromatosis type 1: clinical report and literature review. |
Page: 1